US Patent Number

9198981

Publication Date

12-1-2015

Abstract

This invention relates to compounds, composJtwns, and methods for the treatment of traits, diseases and conditions that respond to the modulation of angiogenic growth factor bioavailability or biological activity.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

11/582,662

Filing Date

10/17/2006

Included in

Ophthalmology Commons

Share

COinS